{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:28:35Z","timestamp":1782516515092,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Type 1 diabetes (T1D) is a chronic autoimmune illness that results in loss of pancreatic beta cells and insulin insufficiency. MicroRNAs (miRNAs) are linked to immune system functions contributing to the pathophysiology of T1D, miRNA-375 is significantly expressed in the human pancreas and its circulatory levels might correspond to beta cell alterations. Pancreatic islet cell antibodies (ICA) and Glutamic acid decarboxylase antibodies (GADA) have roles in autoimmune pathogenesis and are predictive markers of T1D. The aim of this work was to detect serum level changes of miRNA-375, ICA, and GADA in T1D patients, and their siblings compared to healthy controls and correlate them with T1D biochemical parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study included 66 T1D patients (32 males and 34 females; age range 3\u201318 years), 22 patients\u2019 siblings (13 males and 9 females; age range 4\u201317 years), and 23 healthy controls (7 males and 16 females; age range 4\u201317 years). MiRNA-375 levels were measured using quantitative reverse transcription polymerase chain reaction (RT-qPCR), while ICA and GADA levels were measured using enzyme-linked immunosorbent assay (ELISA). Data analysis was done utilizing SPSS-17 software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>MiR-375 levels were downregulated in T1D patients and further decreased in their siblings when compared to healthy controls. Furthermore, miR-375 exhibited inverse correlations with HbA1c levels but no correlations with Total Insulin Dose, disease duration, or autoantibodies (GADA &amp; ICA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study indicates that miR-375 is significantly downregulated in children with T1D and their siblings, suggesting its potential role as a biomarker for beta-cell function and glycemic control.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40618-024-02474-4","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T10:02:20Z","timestamp":1729850540000},"page":"757-764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MiR-375: it could be a general biomarker of metabolic changes and inflammation in type 1 diabetes patients and their siblings"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3235-7181","authenticated-orcid":false,"given":"Eman A.","family":"Mostafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagwa Abdallah","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M. Nour","family":"El Din Abd El Baky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek F.","family":"ElShaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingy","family":"Ashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaa Ahmed","family":"Wahby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Magdy Abdel","family":"Wahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Hamdy Abd El Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"issue":"12","key":"2474_CR1","doi-asserted-by":"publisher","first-page":"10012","DOI":"10.3390\/ijms241210012","volume":"24","author":"E Kawasaki","year":"2023","unstructured":"Kawasaki E (2023) Anti-islet autoantibodies in Type 1 diabetes. Int J Mol Sci 24(12):10012. https:\/\/doi.org\/10.3390\/ijms241210012PMID: 37373160; PMCID: PMC10298549","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2474_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1530\/EC-17-0248","volume":"6","author":"TS Assmann","year":"2017","unstructured":"Assmann TS, Recamonde-Mendoza M, De Souza BM, Crispim D (2017) MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis. Endocr Connect 6(8):773\u2013790. https:\/\/doi.org\/10.1530\/EC-17-0248","journal-title":"Endocr Connect"},{"key":"2474_CR3","doi-asserted-by":"publisher","unstructured":"Marchand L, Jalabert A, Meugnier E et al (2016) miRNA-375 a sensor of glucotoxicity is altered in the serum of children with newly diagnosed type 1 diabetes. J Diabetes Res.; 2016:1869082. https:\/\/doi.org\/10.1155\/2016\/1869082","DOI":"10.1155\/2016\/1869082"},{"issue":"11","key":"2474_CR4","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00125-018-4712-1","volume":"61","author":"EK Sims","year":"2018","unstructured":"Sims EK, Evans-Molina C, Tersey SA, Eizirik DL, Mirmira RG (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61(11):2259\u20132265. https:\/\/doi.org\/10.1007\/s00125-018-4712-1","journal-title":"Diabetologia"},{"issue":"4","key":"2474_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/apha.12460","volume":"213","author":"VA Salunkhe","year":"2015","unstructured":"Salunkhe VA, Esguerra JL, Ofori JK et al (2015) Modulation of microRNA-375 expression alters voltage-gated na (+) channel properties and exocytosis in insulin-secreting cells. Acta Physiol (Oxf) 213(4):882\u2013892. https:\/\/doi.org\/10.1111\/apha.12460","journal-title":"Acta Physiol (Oxf)"},{"key":"2474_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature03076","volume":"432","author":"MN Poy","year":"2004","unstructured":"Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226\u2013230. https:\/\/doi.org\/10.1038\/nature03076","journal-title":"Nature"},{"key":"2474_CR7","doi-asserted-by":"publisher","first-page":"31479","DOI":"10.1038\/srep31479","volume":"6","author":"AA Seyhan","year":"2016","unstructured":"Seyhan AA, Nunez Lopez YO, Xie H et al (2016) Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep 6:31479","journal-title":"Sci Rep"},{"key":"2474_CR8","volume-title":"The IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2011","unstructured":"International Diabetes Federation (2011) The IDF Diabetes Atlas, 5th edn. International Diabetes Federation, Brussels. http:\/\/www.idf.org\/idf-diabetes-atlas-fifth-edition Date of last access 23th April 2013","edition":"5"},{"issue":"1","key":"2474_CR9","doi-asserted-by":"publisher","first-page":"100343","DOI":"10.1016\/j.jgeb.2023.100343","volume":"22","author":"EA Mostafa","year":"2024","unstructured":"Mostafa EA, Abo Hashish MMA, Ismail NA et al (2024) Assessment of vitamin D status and vitamin D receptor polymorphism in Egyptian children with type 1 diabetes. J Genet Eng Biotechnol 22(1):100343. https:\/\/doi.org\/10.1016\/j.jgeb.2023.100343","journal-title":"J Genet Eng Biotechnol"},{"issue":"5","key":"2474_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/jpc.14746","volume":"56","author":"M Karaoglan","year":"2020","unstructured":"Karaoglan M, Keskin M (2020) Incidence of new-onset type 1 diabetes in siblings of index cases with type 1 diabetes within the first 11 years in Turkish children. J Paediatr Child Health 56(5):791\u2013796. https:\/\/doi.org\/10.1111\/jpc.14746Epub 2020 Jan 7. PMID: 31909514.)","journal-title":"J Paediatr Child Health"},{"key":"2474_CR11","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care (2016);39 Suppl 1: S13-22. Erratum in: Diabetes Care. 2016;39(9):1653. https:\/\/doi.org\/10.2337\/dc16-S005","DOI":"10.2337\/dc16-S005"},{"key":"2474_CR12","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1007\/s13277-015-3092-0","volume":"36","author":"J Yin","year":"2015","unstructured":"Yin J, Hou P, Wu Z et al (2015) Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma. Tumor Biol 36:4501\u20134507. https:\/\/doi.org\/10.1007\/s13277-015-3092-0","journal-title":"Tumor Biol"},{"issue":"2","key":"2474_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/dme.12081","volume":"30","author":"A Pugliese","year":"2013","unstructured":"Pugliese A (2013) The multiple origins of type 1 diabetes. Diabet Med 30(2):135\u2013146. https:\/\/doi.org\/10.1111\/dme.12081","journal-title":"Diabet Med"},{"key":"2474_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/JMISR.JMISR_45_20","volume":"4","author":"GF Oreby","year":"2021","unstructured":"Oreby GF, Quashwa SH, Amer ER (2021) Vitamin D and vitamin D-binding protein in type 1 diabetes mellitus. J Med Sci Res 4:276\u2013281. https:\/\/doi.org\/10.4103\/JMISR.JMISR_45_20","journal-title":"J Med Sci Res"},{"key":"2474_CR15","unstructured":"International Diabetes Federation. The IDF Diabetes Atlas, 10th edn. Brussels, Belgium (2021) https:\/\/www.diabetesatlas.org"},{"issue":"8","key":"2474_CR16","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00125-017-4294-3","volume":"60","author":"IV Snowhite","year":"2017","unstructured":"Snowhite IV, Allende G, Sosenko J, Pastori RL, Messinger Cayetano S, Pugliese A (2017) Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes. Diabetologia 60(8):1409\u20131422. https:\/\/doi.org\/10.1007\/s00125-017-4294-3","journal-title":"Diabetologia"},{"issue":"5","key":"2474_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00281-014-0438-4","volume":"36","author":"P In\u2019t Veld","year":"2014","unstructured":"In\u2019t Veld P (2014) Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol 36(5):569\u2013579. https:\/\/doi.org\/10.1007\/s00281-014-0438-4","journal-title":"Semin Immunopathol"},{"issue":"11","key":"2474_CR18","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1084\/jem.20061692","volume":"203","author":"BS Cobb","year":"2006","unstructured":"Cobb BS, Hertweck A, Smith J et al (2006) A role for Dicer in immune regulation. J Exp Med 203(11):2519\u20132527. https:\/\/doi.org\/10.1084\/jem.20061692","journal-title":"J Exp Med"},{"key":"2474_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/cmi.2017.7","volume":"14","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Wang Z, Zhou Z, MiRNAs (2017) Novel regulators of autoimmunity-mediated pancreatic _-cell destruction in type 1 diabetes. Cell Mol Immunol 14:488\u2013496","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"2474_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.gep.2008.12.003","volume":"9","author":"M Correa-Medina","year":"2009","unstructured":"Correa-Medina M, Bravo-Egana V, Rosero S et al (2009) MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr Patterns 9(4):193\u2013199. https:\/\/doi.org\/10.1016\/j.gep.2008.12.003","journal-title":"Gene Expr Patterns"},{"issue":"6","key":"2474_CR21","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.21608\/ejhm.2020.131134","volume":"81","author":"AM Ismail","year":"2020","unstructured":"Ismail AM, Mohammed AE, El-Moneim HM (2020) Risk factors of type 1 diabetes Mellitus in Children Attending Aswan University Hospital. Egypt J Hosp Med 81(6):2265\u20132273. https:\/\/ejhm.journals.ekb.eg\/","journal-title":"Egypt J Hosp Med"},{"issue":"2","key":"2474_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jcjd.2018.02.008","volume":"42","author":"ML Downie","year":"2018","unstructured":"Downie ML, Ulrich EH, Noone DG (2018) An update on hypertension in children with type 1 diabetes. Can J Diabetes 42(2):199\u2013204. https:\/\/doi.org\/10.1016\/j.jcjd.2018.02.008","journal-title":"Can J Diabetes"},{"key":"2474_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.abst.2023.05.001","volume":"5","author":"ST Raza","year":"2023","unstructured":"Raza ST, Rizvi S, Afreen S et al (2023) Association of the circulating micro-RNAs with susceptible and newly diagnosed type 2 diabetes mellitus cases. Adv Biomark Sci Technol 5:57\u201367. https:\/\/doi.org\/10.1016\/j.abst.2023.05.001","journal-title":"Adv Biomark Sci Technol"},{"issue":"1","key":"2474_CR24","doi-asserted-by":"publisher","first-page":"e55272","DOI":"10.1371\/journal.pone.0055272","volume":"8","author":"M Van de Bunt","year":"2013","unstructured":"Van de Bunt M, Gaulton KJ, Parts L et al (2013) The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS ONE 8(1):e55272. https:\/\/doi.org\/10.1371\/journal.pone.0055272","journal-title":"PLoS ONE"},{"issue":"6","key":"2474_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00592-019-01297-7","volume":"56","author":"L Bertoccini","year":"2019","unstructured":"Bertoccini L, Sentinelli F, Incani M et al (2019) Circulating miRNA-375 levels are increased in autoantibodies-positive first-degree relatives of type 1 diabetes patients. Acta Diabetol 56(6):707\u2013710. https:\/\/doi.org\/10.1007\/s00592-019-01297-7","journal-title":"Acta Diabetol"},{"issue":"10","key":"2474_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00109-015-1296-9","volume":"93","author":"M Latreille","year":"2015","unstructured":"Latreille M, Herrmanns K, Renwick N et al (2015) miR-375 gene dosage in pancreatic \ud6fd-cells: implications for regulation of \ud6fd- cell mass and biomarker development. J Mol Med 93(10):1159\u20131169. https:\/\/doi.org\/10.1007\/s00109-015-1296-9","journal-title":"J Mol Med"},{"issue":"6","key":"2474_CR27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2337\/dc15-0144","volume":"38","author":"MA Atkinson","year":"2015","unstructured":"Atkinson MA, von Herrath M, Powers AC, Clare-Salzler M (2015) Current concepts on the pathogenesis of type 1 diabetes\u2014considerations for attempts to prevent and reverse the disease. Diabetes Care 38(6):979\u2013988. https:\/\/doi.org\/10.2337\/dc15-0144","journal-title":"Diabetes Care"},{"issue":"6","key":"2474_CR28","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2337\/dc18-2282","volume":"42","author":"JP Krischer","year":"2019","unstructured":"Krischer JP, Liu X, Vehik K et al (2019) TEDDY Study Group. Predicting Islet Cell autoimmunity and type 1 diabetes: an 8-Year TEDDY Study Progress Report. Diabetes Care 42(6):1051\u20131060. https:\/\/doi.org\/10.2337\/dc18-2282","journal-title":"Diabetes Care"},{"key":"2474_CR29","doi-asserted-by":"publisher","first-page":"11634","DOI":"10.1038\/s41598-023-38615-7","volume":"13","author":"D Swolin-Eide","year":"2023","unstructured":"Swolin-Eide D, Forsander G, Pundziute Lyck\u00e5 A et al (2023) Circulating microRNAs in young individuals with long-duration type 1 diabetes in comparison with healthy controls. Sci Rep 13:11634. https:\/\/doi.org\/10.1038\/s41598-023-38615-7","journal-title":"Sci Rep"},{"key":"2474_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.phrs.2013.06.005","volume":"75","author":"Y Mao","year":"2013","unstructured":"Mao Y, Mohan R, Zhang S, Tang X (2013) MicroRNAs as pharmacological targets in diabetes. Pharmacol Res 75:37\u201347","journal-title":"Pharmacol Res"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02474-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02474-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02474-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T10:27:48Z","timestamp":1740997668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02474-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2474"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02474-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was approved by the medical ethics committee of the National Research Centre, Cairo, Egypt, NO; 19207.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors approved the final version of this manuscript and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All participants signed a written informed consent after the research protocols were carefully explained to them.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No potential conflict of interest was reported by the author(s).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}